Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase III Chemotherapy with CDDP/5-FU with vs without Immunorestorative Therapy with DTC in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
MDA-DM-8523
NCI-V85-0245
Last Modified:
12/1/1987
2.
Phase II Pilot Study of Toxicity Attenuation with Diethyldithiocarbamate in Patients with Epithelial Ovarian Cancer Receiving High-Dose CACP or High-Dose CBDCA
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care, Treatment
Closed
18 and over
NCI
NCI-87-C-18B
NCI-T87-0055N, T87-0055
Last Modified:
10/1/1989
3.
Phase II Limited Study of Diethyldithiocarbamate to Protect Against CDDP/CTX-Induced Toxicity in Patients with Advanced Malignancies
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care, Treatment
Closed
18 and over
MSKCC-89022
NCI-V89-0109
Last Modified:
9/1/1991
4.
Phase II Study of Second-Line CBDCA with DTC Used as a Bone Marrow Protective Agent in Patients with Ovarian or Fallopian Tube Cancer or Adenocarcinoma of the Peritoneum who have Previously Responded to CDDP- or CBDCA-based Chemotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care, Treatment
Closed
18 and over
MSKCC-91049
NCI-V91-0119
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute